Halotestin

Halotestin is fluoxymesterone — a testosterone derivative with three structural modifications that define everything the compound does: a 17α-methyl group for oral bioavailability, an 11β-hydroxyl that blocks aromatization, and a 9α-fluoro substitution that dramatically increases androgen receptor affinity. The result is a non-aromatizing oral AAS with one of the highest AR binding affinities in the catalog, used almost exclusively as a short-window strength and hardening tool rather than a mass builder.

Androgen Receptor Agonism and CNS Activation#

The 9α-fluoro substitution pushes AR binding affinity well above testosterone, and the 11β-hydroxyl prevents aromatization, so the signal the body receives is pure androgen with no estrogenic counterweight. On paper this gives Halo a high anabolic:androgenic dissociation, but in practice the dominant effect is central — aggression, acute force output, intensity, and a noticeable shift in pain tolerance and competitive drive within 60–90 minutes of a pre-training dose.

"Halotestin (fluoxymesterone) exhibits a very high anabolic:androgenic dissociation in vitro, but in practice is used almost exclusively for its strength-promoting and CNS-activating properties rather than for muscle mass gains." — Kicman AT., British Journal of Pharmacology, 2008

This is the practical outcome lifters and strength athletes actually use it for: a 2–4 week pre-meet or peak-week window where acute 1RM expression matters more than tissue accrual.

Non-Aromatizing, Non-Progestogenic Signaling#

Because the 11β-hydroxyl blocks aromatase access, Halo produces zero estrogenic output — no gyno risk from the compound itself, no water retention, no estrogen-mediated fat storage. Combined with its antagonism at the glucocorticoid receptor at supraphysiologic doses, this drives the "dry, hard, grainy" cosmetic effect bodybuilders chase in the final weeks of contest prep. Gains run tight rather than wet, which is why Halo slots into the last 3–4 weeks of prep rather than earlier blocks where hypertrophy matters more.

Erythropoiesis and Oxygen Delivery#

Halo is a strong stimulator of red blood cell production — historically it was FDA-approved for anemia precisely because of this effect.

"Administration of fluoxymesterone produced an increase in reticulocyte count, erythrocyte count, hemoglobin, and hematocrit values in most cases, establishing its action in stimulating erythropoiesis." — Gardner FH, Pringle JC Jr., Archives of Internal Medicine, 1961

For the strength athlete, higher hematocrit means better oxygen delivery under load and faster between-set recovery on heavy singles. The tradeoff is that stacking Halo on top of a base that already elevates RBC (testosterone, EQ, tren) can push hematocrit into donation territory fast — check bloodwork at day 14.

SHBG Suppression and Free Androgen Amplification#

Halo meaningfully suppresses sex hormone-binding globulin, which raises the free fraction of any co-administered androgens. This is part of why a modest 20–30 mg/day Halo dose stacked on 300–500 mg/week of testosterone punches harder than either compound would suggest in isolation — the base androgens become more bioavailable at the tissue level. It's also why Halo pairs so well with high-SHBG-binding compounds like testosterone and nandrolone in a peak protocol.

Hepatic Metabolism and the Cost of the 17α-Methyl Group#

The 17α-methylation that makes Halo orally active also makes it severely hepatotoxic. Fluoxymesterone is one of the more cholestatic orals in circulation and is processed primarily through hepatic 6β-hydroxylation before conjugation and urinary excretion.

"Fluoxymesterone (Halotestin) is a potent synthetic androgenic steroid with very strong hepatotoxic potential, largely due to its 17α-methylation and 9α-fluoro substitution. It does not aromatize to estrogen and is considered one of the most cholestatic oral AAS." — Grant B et al., Annals of the New York Academy of Sciences, 2024

"Fluoxymesterone is subject to extensive hepatic metabolism with 6β-hydroxylation being the major pathway; its metabolites are detectable in urine for several weeks after discontinuation, presenting significant risk for tested athletes." — Schänzer W., Clinical Chemistry, 1996

Two practical takeaways: first, the liver cost is why cycles are hard-capped at 4 weeks with TUDCA 500–1000 mg/day and NAC 1200–1800 mg/day running throughout. Second, the weeks-long urinary detection window makes Halo a non-starter for anyone subject to drug testing — WADA, USAPL, tested federations, or employment screens.

Lipid and Vascular Impact#

Non-aromatizing c17-aa orals hit HDL hard, and Halo is near the top of that list per milligram. Expect HDL to crater and LDL to climb within the first 10–14 days of a 20+ mg/day run, with blood pressure rising from the combined effect of hematocrit elevation and lipid-driven vascular changes. This is mechanistically why the protocol demands a baseline lipid panel, telmisartan on hand, and a hard 4-week ceiling — the damage is dose- and duration-dependent, and short pointed cycles recover where long cycles do not.

Common (most users)#

• Aggression, irritability, short fuse — the defining sensation of Halo. Manage it: don't run it during high-stress life periods, tell your partner what's coming, and keep the dose to what you actually need for the task. If you're snapping at coworkers by week two, you're overdosed.
• Sleep disruption — CNS drive runs hot. Shift the second dose earlier (pre-training rather than late afternoon), and consider magnesium glycinate + a small dose of trazodone or DSIP if sleep collapses.
• Blood pressure rise — noticeable within days. Daily home cuff readings; telmisartan 40–80 mg on standby. Cialis 5 mg daily helps.
• Hematocrit / hemoglobin elevation — expected, part of the mechanism. (Gardner & Pringle 1961) Donate blood if HCT climbs past ~52%, especially if stacked with tren or EQ.
• Acne, oily skin — standard androgenic output. Daily cleanser, keep bedding clean, consider topical clindamycin. Not 5α-reducible, so finasteride won't help with scalp/skin androgenic load here.
• HDL crash, LDL rise — universal on Halo. Citrus bergamot 1,000 mg/day, low-saturated-fat diet, daily cardio. Expect recovery to take 2–3 months post-cycle.

Uncommon (dose-dependent or individual)#

• Elevated LFTs (ALT/AST/GGT/ALP) — the 17α-methyl + 9α-fluoro structure is one of the more cholestatic oral backbones in circulation. (Grant et al. 2024) TUDCA 500–1000 mg/day and NAC 1200–1800 mg/day throughout. Mid-cycle bloodwork at ~day 14; if ALT/AST cross 3× ULN or GGT runs sharply up, cut the dose or end the run.
• Hypertension crossing 140/90 — telmisartan first, Halo dose cut second, discontinue third. Don't ride it out.
• Headaches / pressure sensation — usually a BP or hematocrit signal. Check both before assuming it's "just the Halo."
• Accelerated MPB in predisposed users — topical AR antagonists (RU58841, pyrilutamide) are the community move here since oral 5-AR inhibitors are mechanistically useless against fluoxymesterone itself.
• Libido swings — can run high from CNS drive or crater from suppression depending on the base. A solid testosterone base (200–500 mg/week) smooths this out.
• Appetite suppression — makes Halo unpleasant during aggressive cuts; eat on a schedule rather than to hunger.

Rare but serious#

• Cholestatic jaundice — scleral icterus (yellowing of the whites of the eyes), dark urine, pale stool, right-upper-quadrant discomfort, severe itching. Stop immediately and get LFTs + bilirubin drawn. Risk climbs sharply past 4 weeks of use.
• Hepatic peliosis — blood-filled cysts in the liver, associated with prolonged c17-aa use. Another reason cycles are capped at 4 weeks.
• Polycythemia-related thrombotic events — stroke, DVT, PE. The combination of Halo + tren + a high-hematocrit baseline is where this actually happens. Monitor HCT, donate blood as needed, and be aware of unilateral calf swelling, sudden dyspnea, or neurological changes.
• Cardiac remodeling / arrhythmia at prolonged use — not a 3–4 week concern at sane doses, but users who push Halo past 6–8 weeks are rolling this dice.
• Severe mood disturbance — intrusive anger, reduced empathy, paranoia. If people around you are telling you you've changed, believe them and end the run.

Hard contraindications#

• Untreated hypertension or dyslipidemia — Halo makes both dramatically worse within days. Get BP and lipids in range before initiating the run, not during.
• Existing liver enzyme elevation or active hepatotoxic stack — do not run Halo alongside superdrol, M1T, or high-dose winstrol. Pick one hepatotoxic oral per window.
• History of cholestasis on prior orals — your liver has already told you. Don't re-test it with the most cholestatic oral on the menu.
• Drug-tested competition — metabolites are detectable in urine for weeks after discontinuation. (Schänzer 1996) Halo is not a compound you "cycle off in time" for a test.
• Women — the androgenic load is severe and virilization (voice deepening, clitoral hypertrophy, jawline and hair-pattern changes) is irreversible. Even in female strength-sport circles where heavier androgens circulate, Halo is considered off-limits.
• Pregnancy or potential pregnancy — teratogenic; do not use.

PCT and gender considerations#

Halo's 3–4 week window limits HPTA damage compared to longer runs, but suppression still occurs. If Halo is layered onto a testosterone base (the standard approach), continue the base protocol and no separate PCT is needed for the Halo itself. If run without a test base — unusual and not recommended — standard SERM PCT applies: Nolvadex 20 mg/day × 4 weeks + Clomid 25–50 mg/day × 4 weeks, starting 24 hours after the last Halo dose given its ~9 hour half-life. Bloodwork (total T, free T, LH, FSH, estradiol) at 6–8 weeks post to confirm recovery.

"Halo has a reputation as a specialist tool—most commonly pulled out pre-meet or peak-week for strength and aggression. Nobody sane runs it for hypertrophy because at equal liver/lipid cost you could just run Anadrol and grow more." — r/steroids compound thread

Used correctly — 3–4 weeks, capped doses, on a stable base, with TUDCA/NAC, mid-cycle bloodwork, and a BP cuff on the nightstand — Halo's side effect profile is manageable. Used as a general-purpose oral or stretched past 4 weeks, it's one of the harshest compounds in the catalog. Respect the ceiling and it does its job.